POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 19 17:20 ET
Ensysce Biosciences | 8-K: Current report
Mar 29 08:02 ET
Ensysce Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mar 26 16:46 ET
Ensysce Biosciences | 8-K: Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 15 08:15 ET
Ensysce Biosciences | 8-K: Current report
Feb 14 17:35 ET
Ensysce Biosciences | S-1: General form for registration of securities under the Securities Act of 1933
Jan 17 00:00 ET
Ensysce Biosciences | 8-K: Current report
Dec 29, 2023 00:00 ET
Ensysce Biosciences | DEFA14A: Others
Dec 19, 2023 16:27 ET
Ensysce Biosciences | 8-K: Current report
Dec 19, 2023 16:24 ET
Ensysce Biosciences | 8-K: Current report
Nov 29, 2023 09:24 ET
Ensysce Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Nov 17, 2023 17:19 ET
Ensysce Biosciences | 8-K: Current report
Nov 17, 2023 16:15 ET
Ensysce Biosciences | DEFA14A: Others
Nov 9, 2023 21:25 ET
Ensysce Biosciences | DEF 14A: Definitive information statements
Nov 9, 2023 21:22 ET
Ensysce Biosciences | S-1: General form for registration of securities under the Securities Act of 1933
Nov 9, 2023 17:06 ET
Ensysce Biosciences | 8-K: Ensysce Biosciences Reports Third Quarter 2023 Financial Results
Nov 9, 2023 17:02 ET
Ensysce Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Oct 30, 2023 17:04 ET
Ensysce Biosciences | 8-K: Current report
Oct 24, 2023 07:59 ET
Ensysce Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Oct 19, 2023 19:48 ET
Ensysce Biosciences | 8-K: Current report
Aug 28, 2023 17:20 ET
No Data
No Data